201 Valuation27 Sep 2020 19:00
Rhubarb you said:
“ Hard to place a figure; similar markets typically generation 500m in instalments up to Phase 1 commencement, with single digit royalties on release for IP transfer. But with these recent acquisitions, many are still early preclinical; this one is far, far, beyond that stage. So worth much more if sold rather than partnered.”
And
“So, in essence, and I never thought I'd type this, Saint Ts estimates are on the rather - ahem - conservative side. :-o Either way, if the results are even "good", the cash runway position shouldn't be an issue again.“
What is defined as good please?
And really.... circa $500 mn if good?
Thats £6.75 ps!